| Literature DB >> 29150432 |
Cagri Bodur1, Dubek Kazyken1, Kezhen Huang1, Bilgen Ekim Ustunel1, Kate A Siroky1, Aaron Seth Tooley1, Ian E Gonzalez1, Daniel H Foley1, Hugo A Acosta-Jaquez1, Tammy M Barnes2, Gabrielle K Steinl2, Kae-Won Cho3, Carey N Lumeng3, Steven M Riddle4, Martin G Myers2, Diane C Fingar5.
Abstract
The innate immune kinase TBK1 initiates inflammatory responses to combat infectious pathogens by driving production of type I interferons. TBK1 also controls metabolic processes and promotes oncogene-induced cell proliferation and survival. Here, we demonstrate that TBK1 activates mTOR complex 1 (mTORC1) directly. In cultured cells, TBK1 associates with and activates mTORC1 through site-specific mTOR phosphorylation (on S2159) in response to certain growth factor receptors (i.e., EGF-receptor but not insulin receptor) and pathogen recognition receptors (PRRs) (i.e., TLR3; TLR4), revealing a stimulus-selective role for TBK1 in mTORC1 regulation. By studying cultured macrophages and those isolated from genome edited mTOR S2159A knock-in mice, we show that mTOR S2159 phosphorylation promotes mTORC1 signaling, IRF3 nuclear translocation, and IFN-β production. These data demonstrate a direct mechanistic link between TBK1 and mTORC1 function as well as physiologic significance of the TBK1-mTORC1 axis in control of innate immune function. These data unveil TBK1 as a direct mTORC1 activator and suggest unanticipated roles for mTORC1 downstream of TBK1 in control of innate immunity, tumorigenesis, and disorders linked to chronic inflammation.Entities:
Keywords: IFN‐β; TBK1; mTOR; mTORC1
Mesh:
Substances:
Year: 2017 PMID: 29150432 PMCID: PMC5753041 DOI: 10.15252/embj.201696164
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598